Table 3.
Studies reporting an overall work-related musculoskeletal disorder, treatment, or disability prevalence
| Author | Survey tool | Number surveyed | Overall work-related MSD prevalence | Treatment prevalence of work-related MSDs | Work-related MSDs leading to disability |
| Cohen-Rosenblum et al. [23] | De Novo | 63 | 68.3% (43) | NR | 9.3% (4) |
| Davis et al. [24] | De Novo | 140 | 44% (61) | 39% (34) | 23% (14) |
| Fram et al. [27] | De Novo | 204 | 69.1% (141) | 47.5% (67) | NR |
| McQuivey et al. [53] | De Novo | 76 | 97% (74) | 62% (46) | NR |
| McQuivey et al. [52] | De Novo | 521 | 97% (503) | 62% (312) | NR |
| Alaseem et al. [5] | PDS | 67 | 76.1% (51) | 27.5% (14) | 33.3% (17) |
| Alqahtani et al. [9] | PDS | 183 | 66.1% (121) | NR | 27.3% (33) |
| Alqahtani et al. [8] | PDS | 86 | 66.3% (57) | NR | 26.3% (15) |
| Alqahtani et al. [7] | PDS | 578 | 60.4% (349) | 73.1% (255) | 29.2% (102) |
| Alzahrani et al. [12] | PDS | 402 | 66.9% (269) | NR | 30.9% (83) |
| Alzahrani et al. [11] | PDS | 142 | 89.4% (127) | 82.7% (105) | 26.0% (33) |
| Swank et al. [67] | PDS | 235 | 86% (202) | 27% (55) | 14% (28) |
| Al-Mohrej et al. [6] | NMQ | 179 | 67% (120) | NR | NR |
| Caciatori et al. [17] | NMQ | 54 | 37% (20) | NR | NR |
| Tan et al. [68] | NMQ | 56 | 87.5% (49) | NR | NR |
| Bernstein et al. [15] | PCS, PHQ, SHAI | 220 | 83% (183) | 53% (96) | 13% (23) |
MSD = musculoskeletal disorder; PDS = Physical Discomfort Survey; NMQ = Nordic Musculoskeletal Questionnaire; PCS = Pain Catastrophizing Scale; PHQ = Patient Health Questionnaire; SHAI = Short Health Anxiety Inventory; NR = not reported.